Dupixent picks up 9th FDA approval
25 Feb 2026 //
PRESS RELEASE
Protara sees 66% Bladder Cancer Response Rate at 6 Months
25 Feb 2026 //
FIERCE BIOTECH
FDA Approves Pfizer`s BRAFTOVI for First-Line mCRC Treatment
25 Feb 2026 //
PHARMIWEB
Eris, Natco Pharma Partner For Semaglutide Launch In India
25 Feb 2026 //
INDPHARMAPOST
Lupin Launches Brivaracetam Oral Solution In US
25 Feb 2026 //
PRESS RELEASE
FDA Approves Immedica`s Loargys After 4-Year Delay
25 Feb 2026 //
FIERCE PHARMA
Frontier Biotech, GSK Seal Global siRNA Pact
25 Feb 2026 //
PR NEWSWIRE
Abcuro`s KLRG1 Antibody Flunks Phase 2/3 Muscle Disease Study
25 Feb 2026 //
FIERCE BIOTECH
Novo`s UBT251 Hits 19.7% Weight Loss in China Phase 2 Trial
25 Feb 2026 //
GLOBENEWSWIRE
Drugs In Development
Market Intel

Market Place
Sourcing Support